PlainRecalls
FDA Drug Low Class III Terminated

Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19

Reported: April 19, 2017 Initiated: April 4, 2017 #D-0651-2017

Product Description

Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19

Reason for Recall

Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.

Details

Recalling Firm
West-Ward Columbus, Inc.
Units Affected
100 bottles
Distribution
The recalled product was distributed to the following state: OH. There are no Canada accounts for this recall. There are no Mexico accounts for this recall. There are no government accounts for this recall.
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19. Recalled by West-Ward Columbus, Inc.. Units affected: 100 bottles.
Why was this product recalled?
Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 19, 2017. Severity: Low. Recall number: D-0651-2017.